P

ProQuest Investments

50 employees

ProQuest Investments is a New Jersey-based venture capital firm seeking to finance seed- to late-stage healthcare companies.

Investor insights

Sectors invested in

Biotechnology28
Health Care26
Therapeutics14
Medical11
Pharmaceutical6
Medical Device6
Health Diagnostics4
Product Design4
Manufacturing4
Biopharma3
IMPT3
Adaptive Aperture3
Single Room Proton Therapy3
Compact proton therapy3
Proton therapy solutions3
Pencil Beam Scanning Technology3
normal and disease biology2
Genetics2
drug development2
oncology2

Funding rounds participated in

$29M sweet spot round size

Most of their 50 investments are in rounds between $17M and $37M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Health Care
healthcare venture capital
Venture Capital

Date founded

1998

Investments made

S

SomaLogic raised $200M on January 3, 2018

Investors: Nan Fung Life Sciences, Madryn Asset Management, Quest Diagnostics, iCarbonX, Otsuka Holdings Co., Ltd. and ProQuest Investments

R

ReVision Optics raised $32M on November 10, 2016

Investors: Canaan, InterWest Partners, Domain Associates and ProQuest Investments

S

SomaLogic raised $17M on November 17, 2014

Investors: ProQuest Investments

M

Mevion Medical Systems raised $200M on August 4, 2014

Investors: Yuanming Capital, Venrock and ProQuest Investments

T

Telormedix raised $8.4M on December 2, 2013

Investors: Aravis and ProQuest Investments

I

Immune Design Corp raised $49M on October 30, 2013

Investors: Sanofi Ventures, Versant Ventures, Osage University Partners (OUP), The Column Group, Alta Partners and ProQuest Investments

R

ReVision Optics raised $55M on July 29, 2013

Investors: Canaan, Domain Associates, InterWest Partners, RMI Partners and ProQuest Investments

M

Mevion Medical Systems raised $55M on June 25, 2013

Investors: Venrock and ProQuest Investments

R

ReVision Optics raised $15M on April 16, 2013

Investors: RMI Partners, Domain Associates, Canaan and ProQuest Investments

M

Mersana Therapeutics raised $27M on July 31, 2012

Investors: F-Prime Capital Partners and ProQuest Investments

FAQ